Cudeiro, J., Rivadulla, C., Rodriguez, R., Grieve, K.L., Martinez Conde, S. & Acuna, C. (1997) Actions of compounds manipulating the nitric oxide system in the cat primary visual cortex. J. Physiol. Lond., 504, 467–478. Dale, N. & Roberts, A. (1985) Dual-component amino-acid-mediated synaptic potentials: excitatory drive for swimming in Xenopus embryos. J. Physiol., 363, 35–59. Daniel, H., Levenes, C. & Crepel, F. (1998) Cellular mechanisms of cerebellar LTD. Trends Neurosci., 21, 401–407. Daoudal, G. & Debanne, D. (2003) Long-term plasticity of intrinsic excitability: learning rules and mechanisms. Learn. Mem., 10, 456–465. Davies, S. (2000) Nitric oxide signalling in insects. Insect Biochem. Mol. Biol., 30, 1123–1138. Dawson, V.L. & Dawson, T.M. (1998) Nitric oxide in neurodegeneration. Prog. Brain Res., 118, 215–229. De Seranno, S., Estrella, C., Loyens, A., Cornea, A., Ojeda, S.R., Beauvillain, J.C. & Prevot, V. (2004) Vascular endothelial cells promote acute plasticity in ependymoglial cells of the neuroendocrine brain. J. Neurosci., 24, 10353– 10363. De Visscher, G., Springett, R., Delpy, D.T., Van, R.J., Borgers, M. & Van, R.K. (2002) Nitric oxide does not inhibit cerebral cytochrome oxidase in vivo or in the reactive hyperemic phase after brief anoxia in the adult rat. J. Cereb. Blood Flow Metab., 22, 515–519. Deguchi, T. & Yoshioka, M. (1982) l-Arginine identiﬁed as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. J. Biol. Chem., 257, 10147–10151. Del Bel, E.A., Guimaraes, F.S., Bermudez-Echeverry, M., Gomes, M.Z., Schiaveto-de-souza, A., Padovan-Neto, F.E., Tumas, V., Barion-Cavalcanti, A.P., Lazzarini, M., Nucci-da-Silva, L.P. & de Paula-Souza, D. (2005) Role of nitric oxide on motor behavior. Cell. Mol. Neurobiol., 25, 371–392. Demas, G.E., Kriegsfeld, L.J., Blackshaw, S., Huang, P., Gammie, S.C., Nelson, R.J. & Snyder, S.H. (1999) Elimination of aggressive behavior in male mice lacking endothelial nitric oxide synthase. J. Neurosci., 19, RC30. Dessauer, C.W., Tesmer, J.J., Sprang, S.R. & Gilman, A.G. (1999) The interactions of adenylate cyclases with P-site inhibitors. Trends Pharmacol. Sci., 20, 205–210. Dinerman, J.L., Dawson, T.M., Schell, M.J., Snowman, A. & Snyder, S.H. (1994a) Endothelial nitric oxide synthase localized to hippocampal pyrami- dal cells: implications for synaptic plasticity. Proc. Natl Acad. Sci. USA, 91, 4214–4218. Dinerman, J.L., Steiner, J.P., Dawson, T.M., Dawson, V. & Snyder, S.H. (1994b) Cyclic nucleotide dependent phosphorylation of neuronal nitric oxide synthase inhibits catalytic activity. Neuropharmacology, 33, 1245–1251. Ding, J.D., Burette, A., Nedvetsky, P.I., Schmidt, H.H. & Weinberg, R.J. (2004) Distribution of soluble guanylyl cyclase in the rat brain. J. Comp. Neurol., 472, 437–448. Do, K.Q., Binns, K.E. & Salt, T.E. (1994) Release of the nitric oxide precursor, arginine, from the thalamus upon sensory afferent stimulation, and its effect on thalamic neurons in vivo. Neuroscience, 60, 581–586. Dodson, P.D., Billups, B., Rusznak, Z., Szucs, G., Barker, M.C. & Forsythe, I.D. (2003) Presynaptic rat Kv1.2 channels suppress synaptic terminal hyperexcitability following action potential invasion. J. Physiol., 550, 27–33. Doreulee, N., Sergeeva, O.A., Yanovsky, Y., Chepkova, A.N., Selbach, O., Godecke, A., Schrader, J. & Haas, H.L. (2003) Cortico-striatal synaptic plasticity in endothelial nitric oxide synthase deﬁcient mice. Brain Res., 964, 159–163. Dreyer, J., Schleicher, M., Tappe, A., Schilling, K., Kuner, T., Kusumawidijaja, G., Muller-Esterl, W., Oess, S. & Kuner, R. (2004) Nitric oxide synthase (NOS)-interacting protein interacts with neuronal NOS and regulates its distribution and activity. J. Neurosci., 24, 10454–10465. Dudzinski, D.M., Igarashi, J., Greif, D. & Michel, T. (2006) The regulation and pharmacology of endothelial nitric oxide synthase. Annu. Rev. Pharmacol. Toxicol., 46, 235–276. Duncan, A.J. & Heales, S.J. (2005) Nitric oxide and neurological disorders. Mol. Aspects Med., 26, 67–96. Duport, S. & Garthwaite, J. (2005) Pathological consequences of inducible nitric oxide synthase expression in hippocampal slice cultures. Neuroscience, 135, 1155–1166. Dutar, P. & Nicoll, R.A. (1988) A physiological role for GABAB receptors in the central nervous system. Nature, 332, 156–158. Dwivedy, A., Gertler, F.B., Miller, J., Holt, C.E. & Lebrand, C. (2007) Ena ⁄ VASP function in retinal axons is required for terminal arborization but not pathway navigation. Development, 134, 2137–2146. El-Husseini, A.E., Williams, J., Reiner, P.B., Pelech, S. & Vincent, S.R. (1999) Localization of the cGMP-dependent protein kinases in relation to nitric oxide synthase in the brain. J. Chem. Neuroanat., 17, 45–55. Neural nitric oxide transmission 2797 Eliasson, M.J., Blackshaw, S., Schell, M.J. & Snyder, S.H. (1997) Neuronal nitric oxide synthase alternatively spliced forms: prominent functional localizations in the brain. Proc. Natl Acad. Sci. USA, 94, 3396–3401. Endo, S., Suzuki, M., Sumi, M., Nairn, A.C., Morita, R., Yamakawa, K., Greengard, P. & Ito, M. (1999) Molecular identiﬁcation of human G-substrate, a possible downstream component of the cGMP-dependent protein kinase cascade in cerebellar Purkinje cells. Proc. Natl Acad. Sci. USA, 96, 2467–2472. Erusalimsky, J.D. & Moncada, S. (2007) Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. Arterioscler. Thromb. Vasc. Biol., 27, 2524–2531. Estrada, C. & Murillo-Carretero, M. (2005) Nitric oxide and adult neurogenesis in health and disease. Neuroscientist, 11, 294–307. Etherington, S.J. & Everett, A.W. (2004) Postsynaptic production of nitric oxide implicated in long-term depression at the mature amphibian (Bufo marinus) neuromuscular junction. J. Physiol., 559, 507–517. Faraci, F.M. & Breese, K.R. (1993) Nitric oxide mediates vasodilatation in response to activation of N-methyl-d-aspartate receptors in brain. Circ. Res., 72, 476–480. Faraci, F.M. & Brian, J.E. Jr (1995) 7-Nitroindazole inhibits brain nitric oxide synthase and cerebral vasodilatation in response to N-methyl-d-aspartate. Stroke, 26, 2172–2175. Feil, R., Hartmann, J., Luo, C., Wolfsgruber, W., Schilling, K., Feil, S., Barski, J.J., Meyer, M., Konnerth, A., De Zeeuw, C.I. & Hofmann, F. (2003) Impairment of LTD and cerebellar learning by Purkinje cell-speciﬁc ablation of cGMP-dependent protein kinase I. J. Cell Biol., 163, 295–302. Feil, R., Hofmann, F. & Kleppisch, T. (2005) Function of cGMP-dependent protein kinases in the nervous system. Rev. Neurosci., 16, 23–41. Ferrendelli, J.A., Chang, M.M. & Kinscherf, D.A. (1974) Elevation of cyclic GMP levels in central nervous system by excitatory and inhibitory amino acids. J. Neurochem., 22, 535–540. Ferrendelli, J.A., Rubin, E.H. & Kinscherf, D.A. (1976) Inﬂuence of divalent cations on regulation of cyclic GMP and cyclic AMP levels in brain tissue. J. Neurochem., 26, 741–748. Fink, M., Duprat, F., Lesage, F., Reyes, R., Romey, G., Heurteaux, C. & Lazdunski, M. (1996) Cloning, functional expression and brain localization of a novel unconventional outward rectiﬁer K+ channel. EMBO J., 15, 6854–6862. Fitzpatrick, D.A., O’Halloran, D.M. & Burnell, A.M. (2006) Multiple lineage speciﬁc expansions within the guanylyl cyclase gene family. BMC Evol. Biol., 6, 26. Ford, P.C., Wink, D.A. & Stanbury, D.M. (1993) Autoxidation kinetics of aqueous nitric oxide. FEBS Lett., 326, 1–3. Friebe, A. & Koesling, D. (1998) Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol. Pharmacol., 53, 123–127. Friebe, A., Mergia, E., Dangel, O., Lange, A. & Koesling, D. (2007) Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide- sensitive guanylyl cyclase. Proc. Natl Acad. Sci. USA, 104, 7699–7704. Frisch, C., Dere, E., Silva, M.A., Godecke, A., Schrader, J. & Huston, J.P. (2000) Superior water maze performance and increase in fear-related behavior in the endothelial nitric oxide synthase-deﬁcient mouse together with monoamine changes in cerebellum and ventral striatum. J. Neurosci., 20, 6694–6700. Furchgott, R.F. (1999) Endothelium-derived relaxing factor: discovery, early studies, and identiﬁcation as nitric oxide. Biosci. Rep., 19, 235–251. Galle, J., Zabel, U., Hubner, U., Hatzelmann, A., Wagner, B., Wanner, C. & Schmidt, H.H. (1999) Effects of the soluble guanylyl cyclase activator, YC- 1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. Br. J. Pharmacol., 127, 195–203. Garthwaite, J. (1985) Cellular uptake disguises action of l-glutamate on N-methyl-d-aspartate receptors. With an appendix: diffusion of transported amino acids into brain slices. Br. J. Pharmacol., 85, 297–307. Garthwaite, J. (2005) Dynamics of cellular NO-cGMP signaling. Front. Biosci., 10, 1868–1880. Garthwaite, J. (2007) Neuronal nitric oxide synthase and the serotonin transporter get harmonious. Proc. Natl Acad. Sci. USA, 104, 7739–7740. Garthwaite, J. & Boulton, C.L. (1995) Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol., 57, 683–706. Garthwaite, J. & Garthwaite, G. (1987) Cellular origins of cyclic GMP responses to excitatory amino acid receptor agonists in rat cerebellum in vitro. J. Neurochem., 48, 29–39. Garthwaite, J., Charles, S.L. & Chess Williams, R. (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature, 336, 385–388. Garthwaite, J., Southam, E., Boulton, C.L., Nielsen, E.B., Schmidt, K. & Mayer, B. (1995) Potent and selective inhibition of nitric oxide-sensitive ª The Author (2008). Journal Compilation ª Federation of European Neuroscience Societies and Blackwell Publishing Ltd European Journal of Neuroscience, 27, 2783–2802